Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
251. |
ECCT/20/09/06 | Schisto RDT evaluation A performance evaluation of a prototype rapid diagnostic test for the diagnosis of schistosomiasis |
Principal Investigator(s) 1. Sammy Njenga Site(s) in Kenya Kenya Medical Research Institute (KEMRI) |
01-12-2020 |
View |
252. |
ECCT/20/06/01 | IAVI C100 Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults |
Principal Investigator(s) 1. Prof Walter Jaoko Godfrey Jaoko Site(s) in Kenya 1. KAVI-Insitute of Clinical Research, KNH site (Nairobi City county) |
02-12-2020 |
View |
253. |
ECCT/20/09/05 | THE ELLAVI UBT STUDY An investigation into the barriers and facilitators of scaling up the innovative, low-cost Ellavi Uterine Balloon Tamponade for postpartum hemorrhage in Kenya |
Principal Investigator(s) 1. Zahida P Qureshi 2. Omondi Ogutu 3. Alfred Onyango Osoti 4. George Nyakundi Gwako 5. James Soki 6. James Gitonga Site(s) in Kenya 1. Kenyatta National Hospital (Nairobi City county) 2. Mbagathi Hospital (Nairobi City county) 3. St. Marys Mission Hospital (Nairobi City county) |
02-12-2020 |
View |
254. |
ECCT/20/10/04 | yellow fever vaccine CVIA 079 A Phase III double-blind, randomized, active comparator controlled study in healthy Kenyan adolescents, young children and infants to assess the safety and immunogenicity of Beijing Institute of Biologic Products (BIBP) yellow fever vaccine in comparison to a WHO 17D-204 prequalified comparator yellow fever vaccine, as well as lot-to-lot consistency of immune response to the BIBP yellow fever vaccine”, CVIA 079. |
Principal Investigator(s) 1. Dr. Deborah Langat Site(s) in Kenya KEMRI/KERICHO CLINIC RESEARCH CENTRE |
28-12-2020 |
View |
255. |
ECCT/20/10/03 | Commercial Typhoid tests valid Comparative study of commercially available typhoid point of care tests to benchmark current and emerging tools |
Principal Investigator(s) 1. Robert Sanaya Onsare Site(s) in Kenya 1. Mbagathi County Hospital (Nairobi City county) 2. Medical Missionaries of Mary, Reuben Centre Hospital, Mukuru (Nairobi City county) 3. City Council Clinic, Mukuru (Nairobi City county) |
28-12-2020 |
View |
256. |
ECCT/20/08/02 | ALIVE study Evaluation of the effectiveness of IVERMECTIN co-formulation vs ALBENDAZOLE for treatment of for the Treatment of Soil-Transmitted Helminth Infections (Trichuris trichiura, hookworm, Strongyloides stercoralis) in school aged children and Young Adult Subjects (ALIVE Study) |
Principal Investigator(s) 1. Charles Mwandawiro Site(s) in Kenya Kwale |
12-01-2021 |
View |
257. |
ECCT/20/11/01 | GC vaccine study in kenya Protocol Title: USE OF BEXSERO IMMUNIZATION TO DETECT CROSS REACTIVE ANTIGENS AND ANTI-GONOCOCCAL ANTIBODIES IN KEY POPULATIONS IN KENYA. |
Principal Investigator(s) 1. Prof. Eduard Sanders Site(s) in Kenya The KEMRI-Wellcome Trust Research Programme (KWTRP) Kenya Medical Research Institute (KEMRI) / Wellcome Trust Centre for Geographic Medicine Research – Coast (CGMRC) |
10-02-2021 |
View |
258. |
ECCT/20/08/03 | NIH_PREFER Prebiotic galacto-oligosaccharides and lactoferrin for beneficial gut microbiota with iron supplements: an intervention trial in infants in Msambweni, Kwale County, southern coastal Kenya |
Principal Investigator(s) 1. Gary Brittenham Site(s) in Kenya Msambweni County Referral Hospital |
21-02-2021 |
View |
259. |
ECCT/20/11/03 | IMR-SCD-301 A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease |
Principal Investigator(s) 1. Jessie Nyokabi Githanga 2. Videlis Nduba Site(s) in Kenya 1. Kenya Medical Research Institute-Kondele Children\'s Hospital (Kisumu county) 2. The Center For Respiratory Disease Research/KEMRI (Nairobi City county) 3. Gertrude\'s Children\'s Hospital (Nairobi City county) |
24-02-2021 |
View |
260. |
ECCT/20/11/04 | FAST Study Assessments of the EFficacy, the onset-of-Action and the Safety of Tot'héma® in adults with moderate iron deficiency anaemia |
Principal Investigator(s) 1. Naftali Wasindi Busakhala 2. Otieno Odhiambo Fredrick Site(s) in Kenya 1. MOI University Teaching and Referral Hospita (Nandi county) 2. UNIM Research and Training Centre (Kisumu county) 3. Kenyatta National Hospital (Nairobi City county) |
27-02-2021 |
View |